The Deal
Sunday, November 22, 
2:50 am

Bain Capital's Chris Gordon on Quintiles acquisition

  Share     E-Mail    Discussion    Print Story
Published April 3, 2008 at 3:08 PM
Chris Gordon, a principal at Bain Capital LLC, spoke at The Deal's Healthcare Dealmaking Symposium about Bain Capital's acquisition of Quintiles Transnational Corp., a clinical research service for biotech and pharmaceutical companies. "It has a fundamental growth to make this an interesting deal to us," he stated.  -Maria Woehr

Continue reading below

Also on Dealscape


Video thumbnail. Click to play
Click to play


See more video from the Healthcare Dealmaking Symposium

Tags

Categories



Post a comment





The Deal Pipeline

Deal Video


Inside The Deal: Avaya Inc.'s Mohamad Ali on the company's next target.

More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Managing your shareholder base

By Bradford P. Weirick and Joelle Khoury, Gibson Dunn

Growth companies and their PE sponsors should be wary of the pitfalls that arise when they layer on tiers of preferred stock.


Industry Insight

Easing the stress of distressed M&A

By Derek Watson, KPMG

Corporate buyers face numerous complexities when trying to identify the right moment to purchase a distressed asset.


Editor's Note

Editor's letter: Nov. 16, 2009

By Robert Teitelman

Beneath the veneer of Wall Streeters beats the same heart, stirred by the same determinants of behavior.


footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.